Effect of passive tilting duration on the outcome of head-up tilt testing

Acta Cardiologica

Volumn 62, Issue 6, 2007, Pages 547-552

  Lelonek, Malgorzata ^a,b   Stanczyk, Adam ^a   Goch, Jan Henryk ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b Department of Cardiology ^*  (Poland)

Author keywords

HUT protocol; Syncope; Tilting outcome; VASIS response

Indexed keywords

GLYCERYL TRINITRATE;

ADOLESCENT; ADULT; AGED; ARTICLE; BODY MASS; CLINICAL EXAMINATION; CONTROLLED STUDY; HEAD TILTING; HUMAN; HYPERTENSION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PREVALENCE; SYNCOPE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE; SYNCOPE, VASOVAGAL; TILT-TABLE TEST; TIME FACTORS;

EID: 37049028806     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: 10.2143/AC.62.6.2024012     Document Type: Article

References (21)

1. Fitzpatrick AP, Theodorakis G, Vardas P, Sutton R. Methodology of head-up tilt testing in patients with unexplained syncope. J Am Coll Cardiol 1991; 17: 125-30.
2. Kapoor WN, Smith MA, Miller NL. Upright tilt testing in evaluating syncope: a comprehensive literature review. Am J Med 1994; 97: 78-88.
3. Sutton R, Bloomfield DM. Indications, methodology, and classification of result of tilt-table testing. Am J Cardiol 1999; 84: 10Q-19Q.
4. Natale A, Sra J, Akhtar M, Kusmirek L, Tomassoni G, Leonelli F, Newby K, Beheiry S, Pacifico A. Use of sublingual nitroglycerin during head-up tilt table testing in patients > 60 years of age. Am J Cardiol 1998; 82: 1210-3.
5. Raviele A, Menozzi C, Brignole M, Gasparini G, Alboni P, Musso G, Lolli G, Oddone D, Dinelli M, Merredu R. Value of head-up tilt testing potentiated with sublingual nitroglycerin to assess the origin of unexplained syncope. Am J Cardiol 1995; 76: 267-72.
6. Del Rosso A, Bartoli P, Bartoletti A, Brandinelli-Geri A, Bonechi F, Maioli M, Mazza F, Michelucci A, Russo L, Salvetti E, Sansoni M, Zipoli A, Fierro A, Ieri A. Shortened head-up tilt testing potentiated with sublingual nitroglycerin in patients with unexplained syncope. Am Heart J 1998; 135: 564-70.
7. Bloomfield D, Maurer M, Bigger JT Jr. Effects of age on outcome of tilt-table testing. Am J Cardiol 1999; 83: 1055-8.
8. Brignole M, Alboni P, Benditt D, Bergfeldt L, Blanc JJ, Bloch Thomsen PE, van Dijk JG, Fitzpatrick A, Hohnloser S, Janousek J, Kapoor W, Kenny RA, Kulakowski P, Moya A, Raviele A, Sutton R, Theodorakis G, Wieling W. Guidelines on management (diagnosis and treatment) of syncope. Task Force on syncope, European Society of Cardiology. Eur Heart J 2001; 22: 1256-306.
9. Mussi C, Tolve I, Foroni M, Valli A, Ascari S, Salvioli G. Specificity and total positive rate of head-up tilt testing potentiated with sublingual nitroglycerin in older patients with unexplained syncope. Aging 2001; 13: 105-11.
10. McGavigan A, Hood S. The influence of sex and age on response to head-up tilt-table testing in patients with recurrent syncope. Age Ageing 2001; 30: 295-8.
11. Kurbaan AS, Franzen AC, Bowker TJ, Williams TR, Kaddoura S, Petersen ME, Sutton R. Usefulness of tilt test-induced patterns of heart rate and blood pressure using a two stage protocol with glyceryl trinitrate provocation in patients with syncope of unknown origin. Am J Cardiol 1999; 84: 665-760.
12. Aerts AJ, Dendale P. Diagnostic value of nitrate stimulated tilt testing without preceding passive tilt in patients with suspected vasovagal syncope and a healthy control group. Pacing Clin Electrophysiol 2005; 28: 29-32.
13. Bartoletti A, Alboni P, Ammirati F, Brignole M, Del Rosso A, Foglia Manzillo G, Menozzi C, Raviele A, Sutton R. 'The Italian Protocol': a simplified head-up tilt testing potentiated with oral nitroglycerin to assess patients with unexplained syncope. Europace 2000; 2: 339-42.
14. Lacunza Ruiz J, Garcia Alberola A, Sanchez Munoz JJ, Sanchez JM, Lazaro CL, Martinez JB, Chavarri MV. Head-up tilt test potentiated with nitroglycerin. What is the optimal duration of the test after administration of the drug? Rev Esp Cardiol 2002; 55: 713-7.
15. Stein KM, Slotwiner DJ, Mittal S, Scheiner M, Markowitz SM, Lerman BB. Formal analysis of the optimal duration of tilt testing for the diagnosis of neurally mediated syncope. Am Heart J 2001; 141: 282-8.
16. Sheldon R. Effects of aging on responses to isoproterenol tilt-table testing in patients with syncope. Am J Cardiol 1994; 74: 459-63.
17. Giese AE, Li V, McKnite S, Sakagucho S, Ermis C, Samniah N, Benditt DG. Impact of age and blood pressure on the lower arterial pressure limit for maintenance of consciousness during passive upright posture in healthy vasovagal fainters: preliminary observations. Europace 2004; 6: 457-62.
18. Kozluk E, Kozlowski D, Szufladowicz E, Gajek J, Krupa W, Piatkowska A, Zysko D, Zastawna I, Walczak F, Swiatecka G. Results of head-up tilt test in relation to the protocol used. The pilot results of the Polish multicenter study. Folia Card 2002; 9: 217-25.
19. Strickberger SA, Benson DW, Biaggioni I, Callans DJ, Cohen MI, Ellenbogen KA, Epstein AE, Friedman P, Goldberger J, Heidenreich PA, Klein GJ, Knight BP, Morillo CA, Myerburg RJ, Sila CA. AHA/ACC scientific statement on the evaluation of syncope. Circulation 2006; 113: 316-25.
20. Brignole M, Alboni P, Benditt D, Bergfeldt L, Blanc JJ, Bloch Thomsen PE, van Dijk JG, Fitzpatrick A, Hohnloser S, Janousek J, Kapoor W, Kenny RA, Kulakowski P, Masotti G, Moya A, Raviele A, Sutton R, Theodorakis G, Ungar A, Wieling W. Guidelines on management (diagnosis and treatment) of syncope-update 2004. Executive summary. Eur Heart J 2004; 25: 2054-72.
21. Kulakowski P, Piotrowska D, Konofolska A. Tilt testing: is it necessary in all patients with suspected vaso-vagal syncope? Pacing Clin Electrophysiol 2005; 28: 968-74.